Dr. E. Donnall Thomas and his colleagues discovered a way to treat advanced leukemia by eradicating malignant white blood cells in the bone marrow using high doses of chemotherapy and radiation, and then replacing them with healthy donor cells. This revolutionary approach was the first definitive and reproducible example of the human immune system’s potential to eliminate cancer, and it earned Thomas a Nobel Prize in 1990. Today, cell-based therapies have become a standard of care for many patients with cancer and other diseases.

This first-ever symposium will feature leading researchers from around the world sharing their current research on improving survival after hematopoietic transplantation, adoptive cell therapy, gene therapy and hybrid therapies.

This conference will be held virtually for external attendees. In-person attendance is limited to Fred Hutchinson Cancer Center staff and Consortium members.